Advances in the surgical treatment of esophageal cancer

Journal of Surgical Oncology

Volumn 101, Issue 8, 2010, Pages 725-729

  Thomas, N G ^a   Vezeridis, Michael P ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Anastomotic leak; Minimally invasive esophagectomy; Three field esophagectomy; Transhiatal esophagectomy; Transthoracic esophagectomy

Indexed keywords

CISPLATIN;

CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FOLLOW UP; HUMAN; MINIMALLY INVASIVE SURGERY; MORBIDITY; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; REVIEW; SURGEON;

COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; HUMANS; SURGICAL PROCEDURES, MINIMALLY INVASIVE;

EID: 77952970478     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21566     Document Type: Review

References (46)

1. Lewis I: The surgical treatment of carcinoma of the oesophagus with special reference to a new operation for growths of the middle third. Br J Surg 1946;34:18-31.
2. McKeown KC: Total three-stage oesophagectomy for cancer of the oesophagus. Br J Surg 1976;63:259-262.
3. Orringer MB, Marshall B, Iannettoni MD: Transhiatal esophagectomy: Clinical experience and refinements. Ann Surg 1999;230:392-403. (Pubitemid 30191869)
4. Orringer MB, Marshall B, Chang AC, et al.: Two thousand transhiatal esophagectomies: Changing trends, lessons learned. Ann Surg 2007;246:363-372. (Pubitemid 47312120)
5. Goldminc M, Maddern G, Le Prise E, et al.: Oesophagectomy by a transhiatal approach or thoracotomy: A prospective randomized trial. Br J Surg 1993;80:367-370. (Pubitemid 23091543)
6. Jacobi CA, Zieren HU, Müller JM, et al.: Surgical therapy of esophageal carcinoma: The influence of surgical approach and esophageal resection on cardiopulmonary function. Eur J Cardiothorac Surg 1997;11:32-37.
7. Chu KM, Law SY, Fok M, et al.: A prospective randomized comparison of transhiatal and transthoracic resection for lowerthird esophageal carcinoma. Am J Surg 1997;174:320-324. (Pubitemid 27415363)
8. Hulscher JB, van Sandick JW, de Boer AG, et al.: Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002;347:1662-1669. (Pubitemid 35340784)
9. Omloo JM, Lagarde SM, Hulscher JB, et al.: Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: Five-year survival of a randomized clinical trial. Ann Surg 2007;246:992-1000.
10. Hulscher JB, Tijssen JG, Obertop H, et al.: Transthoracic versus transhiatal resection for carcinoma of the esophagus: A metaanalysis. Ann Thorac Surg 2001;72:306-313. (Pubitemid 32643075)
11. Birkmeyer JD, Stukel TA, Siewers AE, et al.: Surgeon volume and operative mortality in the United States. N Engl J Med 2003;349:2117-2127. (Pubitemid 37464537)
12. Birkmeyer JD, Siewers AE, Finlayson EV, et al.: Hospital volume and surgical mortality in the United States. N Engl J Med 2002;346:1128-1137. (Pubitemid 34984604)
13. Birkmeyer JD, Sun Y, Wong SL, et al.: Hospital volume and late survival after cancer surgery. Ann Surg 2007;245:777-783. (Pubitemid 46684108)
14. Altorki N, Kent M, Ferrara C, et al.: Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg 2002;236:177-183. (Pubitemid 34809536)
15. Bizekis C, Kent MS, Luketich JD, et al.: Initial experience with minimally invasive Ivor Lewis esophagectomy. Ann Thorac Surg 2006;82:402-406.
16. Nguyen NT, Hinojosa MW, Smith BR, et al.: Minimally invasive esophagectomy: Lessons learned from 104 operations. Ann Surg 2008;248:1081-1091.
17. Luketich JD, Alvelo-Rivera M, Buenaventura PO, et al.: Minimally invasive esophagectomy: Outcomes in 222 patients. Ann Surg 2003;238:486-495. (Pubitemid 38176386)
18. Palanivelu C, Prakash A, Senthilkumar R, et al.: Minimally invasive esophagectomy: Thoracoscopic mobilization of the esophagus and mediastinal lymphadenectomy in prone position-Experience of 130 patients. J Am Coll Surg 2006;203:7-16. (Pubitemid 43914491)
19. Avital S, Zundel N, Szomstein S, et al.: Laparoscopic transhiatal esophagectomy for esophageal cancer. Am J Surg 2005;190:69-74. (Pubitemid 40828610)
20. Scheepers JJ, Veenhof AA, van der Peet DL, et al.: Laparoscopic transhiatal resection for malignancies of the distal esophagus: Outcome of the first 50 resected patients. Surgery 2008;143:278-285.
21. Zingg U, McQuinn A, DiValentino D, et al.: Minimally invasive versus open esophagectomy for patients with esophageal cancer. Ann Thorac Surg 2009;87:911-919.
22. Gemmill EH, McCulloch P: Systematic review of minimally invasive resection for gastro-oesophageal cancer. Br J Surg 2007;94:1461-1467. (Pubitemid 350275623)
23. Santillan AA, Farma JM, Meredith KL, et al.: Minimally invasive surgery for esophageal cancer. J Natl Compr Canc Netw 2008;6:879-884.
24. Decker G, Coosemans W, De Leyn P, et al.: Minimally invasive esophagectomy for cancer. Eur J Cardiothorac Surg 2009;35:13-20.
25. Verhage RJ, Hazebroek EJ, Boone J, et al.: Minimally invasive surgery compared to open procedures in esophagectomy for cancer: A systematic review of the literature. Minerva Chir 2009;64:135-146.
26. Biere SS, Cuesta MA, van der Peet DL: Minimally invasive versus open esophagectomy for cancer: A systematic review and metaanalysis. Minerva Chir 2009;64:121-133.
27. Orringer MB, Marshall B, Iannettoni MD: Eliminating the cervical esophagogastric anastomotic leak with a side-to-side stapled anastomosis. J Thorac Cardiovasc Surg 2000;119:277-288. (Pubitemid 30091801)
28. Ercan S, Rice TW, Murthy SC, et al.: Does esophagogastric anastomotic technique influence the outcome of patients with esophageal cancer? J Thorac Cardiovasc Surg 2005;129:623-631.
29. Freeman RK, Ascioti AJ, Wozniak TC: Postoperative esophageal leak management with the Polyflex esophageal stent. J Thorac Cardiovasc Surg 2007;133:333-338. (Pubitemid 46136263)
30. Langer FB, Wenzl E, Prager G, et al.: Management of postoperative esophageal leaks with the Polyflex self-expanding covered plastic stent. Ann Thorac Surg 2005;79:398-403. (Pubitemid 40186525)
31. Dai YY, Gretschel S, Dudeck O, et al.: Treatment of oesophageal anastomotic leaks by temporary stenting with self-expanding plastic stents. Br J Surg 2009;96:887-891.
32. Tuebergen D, Rijcken E, Mennigen R, et al.: Treatment of thoracic esophageal anastomotic leaks and esophageal perforations with endoluminal stents: Efficacy and current limitations. J Gastrointest Surg 2008;12:1168-1176.
33. Walsh TN, Noonan N, Hollywood D, et al.: A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996;335:462-467. (Pubitemid 26269945)
34. Tepper J, Krasna MJ, Niedzwiecki D, et al.: Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol 2008;26:1086-1092.
35. Nygaard K, Hagen S, Hansen HS, et al.: Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 1992;16:1104-1109.
36. Apinop C, Puttisak P, Preecha N: A prospective study of combined therapy in esophageal cancer. Hepatogastroenterology 1994;41:391-393. (Pubitemid 24273251)
37. Le Prise E, Etienne PL, Meunier B, et al.: A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 1994;73:1779-1784. (Pubitemid 24101950)
38. Bosset JF, Gignoux M, Triboulet JP, et al.: Chemoradiotherapy followed by surgery compared with surgery alone in squamouscell cancer of the esophagus. N Engl J Med 1997;337:161-167. (Pubitemid 27306287)
39. Urba SG, Orringer MB, Turrisi A, et al.: Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001;19:305-313. (Pubitemid 32112841)
40. Lee JL, Park SI, Kim SB, et al.: A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma. Ann Oncol 2004;15:947-954.
41. Burmeister BH, Smithers BM, Gebski V, et al.: Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: A randomised controlled phase III trial. Lancet Oncol 2005;6:659-668. (Pubitemid 41222756)
42. Malthaner RA, Wong RK, Rumble RB, et al.: Neoadjuvant or adjuvant therapy for resectable esophageal cancer: A systematic review and meta-analysis. BMC Med 2004;2:35.
43. Fiorica F, Di Bona D, Schepis F, et al.: Preoperative chemoradiotherapy for oesophageal cancer: A systematic review and meta-analysis. Gut 2004;53:925-930. (Pubitemid 38824146)
44. Gebski V, Burmeister B, Smithers BM, et al.: Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: A meta-analysis. Lancet Oncol 2007;8:226-234. (Pubitemid 46291702)
45. Urschel JD, Vasan H: A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 2003;185:538-543.
46. Kaklamanos IG, Walker GR, Ferry K, et al.: Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: A meta-analysis of randomized clinical trials. Ann Surg Oncol 2003;10:754-761. (Pubitemid 40486875)